Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

38.95 +0.55 (+1.43%)
Official Closing Price Updated: 4:10 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,831,433
Open 38.48
Bid (Size) 38.60 (5)
Ask (Size) 39.04 (5)
Prev. Close 38.40
Today's Range 38.33 - 39.40
52wk Range 31.71 - 44.67
Shares Outstanding 5,385,189,617
Dividend Yield 4.41%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ex-Pfizer Exec Pulled Into House Probe Over Alleged COVID Vaccine Delay Through 2020 Election
The committee cited remarks allegedly made by Philip Dormitzer at GSK, claiming that Pfizer’s top R&D leaders delayed clinical trial progress to avoid releasing results before the 2020 election. 
Via Stocktwits
Topics Government Law Enforcement
GSK Rebranded Flovent Asthma Inahler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses
Senator Maggie Hassan is investigating GSK's discontinuation of Flovent HFA, citing increased hospitalizations, higher drug costs, and lost Medicaid rebates. 
Via Benzinga

Performance

YTD
+14.7%
+14.7%
1 Month
-6.5%
-6.5%
3 Month
+0.5%
+0.5%
6 Month
+15.8%
+15.8%
1 Year
+1.5%
+1.5%

More News

Read More
Why This Looming Supreme Court Decision Could Rattle Gilead Sciences
Via Investor's Business Daily
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
From GSK plc
Via Business Wire
AppLovin, First Solar And Li Auto Are Among Top 10 Large Cap Losers Last Week (June 16-20): Are The Others In Your Portfolio?
Via Benzinga
How KalVista Pharma Is Taking On A Rare But Deadly Disease
Via Investor's Business Daily
FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag
Via Benzinga
GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US
From GSK plc
Via Business Wire
GSK’s Application To European Authorities For Expanded Use Of RSV Vaccine In Younger Adults Fails To Rejuvenate Retail Optimism
Via Stocktwits
FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up
Via Benzinga
Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines?
Via Stocktwits
Topics Government
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.
Via Investor's Business Daily
Topics Government
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps
Via Benzinga
Why Is Lyra Therapeutics Stock Surging Over 400% On Monday?
Via Benzinga
Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data
Via Benzinga
Small-Cap Movers Under $1: HIT, SPRO, SGN, PRSO, SGBX Drive Momentum Across AI, Biotech, Crypto, Software, Etc.
Via AB Newswire
Topics Artificial Intelligence
iTeos Therapeutics To Wind Down Operations, Explores Asset Sale: Retail Believes It’s ‘Worth More Selling It Off’
Via Stocktwits
Topics Intellectual Property
Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?
Via Benzinga
GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled
Via Stocktwits
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)
From GSK plc
Via Business Wire
GSK To Buy Phase-3 Ready Liver Disease Drug For Up To $2 Billion
Via Benzinga
iTeos Stock Soars Despite Trial Setback On Liquidation Buzz And Solid Cash Pile
Via Benzinga
Trump’s ‘Most Favored Nation’ Drug Plan Likely To Face Pushback, JP Morgan Analysts Say
Via Stocktwits
Topics ETFs Government Stocks
GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis
From GSK plc
Via Business Wire

Frequently Asked Questions

Is GSK plc American Depositary Shares (Each representing two Ordinary Shares) publicly traded?
Yes, GSK plc American Depositary Shares (Each representing two Ordinary Shares) is publicly traded.
What exchange does GSK plc American Depositary Shares (Each representing two Ordinary Shares) trade on?
GSK plc American Depositary Shares (Each representing two Ordinary Shares) trades on the New York Stock Exchange
What is the ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares)?
The ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares) is GSK on the New York Stock Exchange
What is the current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?
The current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 38.95
When was GSK plc American Depositary Shares (Each representing two Ordinary Shares) last traded?
The last trade of GSK plc American Depositary Shares (Each representing two Ordinary Shares) was at 07/01/25 04:10 PM ET
What is the market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?
The market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 209.75B
How many shares of GSK plc American Depositary Shares (Each representing two Ordinary Shares) are outstanding?
GSK plc American Depositary Shares (Each representing two Ordinary Shares) has 210B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.